• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Genomic Analysis and Tracking of SARS-CoV-2 Variants in Gwangju, South Korea, From 2020 to 2022

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Jun;18(6):e13350.
doi: 10.1111/irv.13350. Genomic Analysis and Tracking of SARS-CoV-2 Variants in Gwangju, South Korea, From 2020 to 2022

Yeong-Un Lee[SUP] 1 [/SUP], Kwangho Lee[SUP] 1 [/SUP], Hongsu Lee[SUP] 1 [/SUP], Jung Wook Park[SUP] 1 [/SUP], Sun-Ju Cho[SUP] 1 [/SUP], Ji-Su Park[SUP] 1 [/SUP], Jeongeun Mun[SUP] 1 [/SUP], Sujung Park[SUP] 1 [/SUP], Cheong-Mi Lee[SUP] 1 [/SUP], Juhye Lee[SUP] 1 [/SUP], Jinjong Seo[SUP] 1 [/SUP], Yonghwan Kim[SUP] 1 [/SUP], Sun-Hee Kim[SUP] 1 [/SUP], Yoon-Seok Chung[SUP] 2 [/SUP]



Affiliations
Free article Abstract

Background: Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in December 2019, it has spread rapidly, and many coronavirus disease (COVID-19) cases have occurred in Gwangju, South Korea. Viral mutations following the COVID-19 epidemic have increased interest in the characteristics of epidemics in this region, and pathogen genetic analysis is required for infection control and prevention.
Methods: In this study, SARS-CoV-2 whole-genome analysis was performed on samples from patients with COVID-19 in Gwangju from 2020 to 2022 to identify the trends in COVID-19 prevalence and to analyze the phylogenetic relationships of dominant variants. B.41 and B.1.497 prevailed in 2020, the early stage of the COVID-19 outbreak; then, B.1.619.1 mainly occurred until June 2021. B.1.617.2, classified as sublineages AY.69 and AY.122, occurred continuously from July to December 2021. Since strict measures to strengthen national quarantine management had been implemented in South Korea until this time, the analysis of mutations was also able to infer the epidemiological relationship between infection transmission routes. Since the first identification of the Omicron variant in late December 2021, the spread of infection has been very rapid, and weekly whole-genome analysis of specimens has enabled us to monitor new Omicron sublineages occurring in Gwangju.
Conclusions: Our study suggests that conducting regional surveillance in addition to nation-level genomic surveillance will enable more rapid and detailed variant surveillance, which will be helpful in the overall prevention and management of infectious diseases.

Keywords: COVID‐19; SARS‐CoV‐2; lineages; variants; whole‐genome sequencing.

 
Back
Top Bottom